Capital Flow Monitor · Sponsors · CIK 2102368
Sernova Biotherapeutics Inc.
PO 29592 RPO Central Parkway, Mississauga, A6, L5A4H2 · (416) 457-4670
Biotechnology · Corporation· inc. ONTARIO, CANADA true
Fit score
—
Offering
$843K
Sold
$345K
% sold
40.9%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-05 | D ·current | 506(b) | $843K | $345K | 40.9% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
James Parsons — Executive Officer, Mississauga, A6
2 other raises
- Junto Capital Partners LP $3.36B of —
- Junto Capital Affiliates LP $1.4M of —
- Jonathan Rigby — Executive Officer / Director, Mississauga, A6
- Bernd Muehlenweg — Director, Mississauga, A6
- John Brooks — Director, Mississauga, A6
- David Paterson — Director, Mississauga, A6
- Steven Sangha — Director, Mississauga, A6
- Tanya Lewis — Director, Mississauga, A6
-
David Burke — Executive Officer, Mississauga, A6
5 other raises
- Selby Lane Private Equity Custom Accounts (Swanson) SPV VII $13.3M of —
- Selby Lane Private Equity Custom Accounts Willowby Fund SPV V $0 of —
- Selby Lane Custom Account IV $0 of —
- Selby Lane Private Equity Custom Accounts SPV III $25.0M of —
- Selby Lane Private Equity Custom Accounts Healthcare SPV II $25.0M of —
- Marylyn Rigby — Executive Officer, Mississauga, A6
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.